Frekuensi Alel Minor Gen Transporter Metformin: SLC22A1 rs628031A>G pada Subyek Sehat Indonesia
Abstract
Full Text:
PDF (Bahasa Indonesia)References
International Diabetes Federation (IDF), Indonesia vs World Prevalence of Diabetes, 2015.
Perkumpulan Endokrinologi Indonesia (Perkeni)., Konsensus Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia, 2015.
Bailey, C.J., 1992. Biguanides and NIDDM. Diabetes Care. 15 (6), pp.755-772.
Stumvoll, M., Nurjhan, N., Perriello, G., Dailey, G., Gerich, J.E., 1995. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. The New England Journal of Medicine, 333 (9), pp.550-554.
Rena, G., Pearson, E.R., dan Sakamoto, K., 2012. Molecular action and pharmacogenetics of metformin: current understanding of an old drug. Diabetes Management, 2 (5), pp.439-452.
Badan Pengawas Obat dan Makanan Republik Indonesia. 2015. Pedoman Bioekivalensi Spesifik Zat Aktif.
Ningrum, dkk., 2017. Hubungan Antara Variasi Genetik pada OCT1 dan MATE1 dengan Farmakokinetik Kadar Tunak dan Farmakodinamika Metformin, Disertasi.
Cook, M.N., Girman, C.J., Stein, P.P., Alexander, C.M., 2007. Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care. Diabetic Medicine, 24, pp.350-358.
Leabman, M.K., Giacomini, K.M., 2003. Estimating the contribution of genes and environment to variation in renal drug clearance. Pharmacogenetics. 2003;13:581– 584.
Graham, G.G., Punt, J., Arora, M., Day, R.O., Doogue, M.P., Du Peter Timminong, J.K., Furlong, T.J., Greenfield, J.R., Greenup, L.C., Kirkpatrick, C.M., Ray, J.E., and Williams, K.M., 2011. Clinical pharmacokinetics of metformin, Clinical Pharmacokinetics, 50 (2), pp.81-98.
Verhaagh S., Schweifer N., Barlow D.P. and Zwart R.: (1999), Cloning of the mouse and human solute carrier 22a3 (slc22a3/SLC22A3) indentifies a conservative cluster of three organic cation transporters on mouse chromosome 17 and human 6q26-q27. Genomics, 55: 209-218.
Kang, H.J., Song, I.S., Shin, H.J., Kim, W.Y., Lee, C.H., Shim, J.C., Zhou, H.H., Lee, S.S., Shin, J.G., 2007. Identification and functional characterization of genetic variants of human organic cation transporters in a Korean population. Drug Metabolism Disposition: The Biolical Fate of Chemicals, 35(4), pp.667-675.
Itoda M, Saito Y, Maekawa K, Hichiya H, Komamura K, Kamakura S, et al. Seven novel single nucleotide polymorphisms in the human SLC22A1 gene encoding organic cation transporter 1 (OCT1). Drug Metab Pharmacokinet. 2004;19:308–12.
Sur, D. 2014. A Tale Of Genetic Variation In The Human Slc22a1 Gene Encoding OCT1 Among Type 2 Diabetes Mellitus Population Groups Of West Bengal, India.
International Journal of Research in Applied, Natural and Social Sciences Vol. 2, Issue 5, 97-106
Ningrum dkk., 2017. Allele Frequencies of Two Main Metformin Transporter Genes: SLC22A1rs628031 A>G and SLC47A1rs2289669 G>A among the Javanese Population in Indonesia. Current Pharmacogenomics and Personalized Medicine, Volume X.
Umamaheswaran, R. G. Praveen, A. S. Arunkumar, A. K. Das, D. G. Shewade, and C. Adithan, ‘Genetic analysis of OCT1 gene polymorphisms in an Indian population’, Indian J. Hum. Genet., vol. 17, no. 3, pp. 164–168, 2011.
Fatchiyah, dkk. 2011. Biologi Molekular, Prinsip Dasar Analisis. Penerbit Erlangga, hal 33-37.
Mato, M, et al., 2018. Genetic polymorphisms of organic cation transporter 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes: A systematic review. Medicine, Vol 97 Issue 27, p e 11349
Schlatter et al., 2014. Mouse organic cation transporter 1 determines properties and regulation of basolateral organic cation transport in renal proximal tubules, Pflüg. Arch. - Eur. J. Physiol., vol. 466, no. 8, pp. 1581–1589, Aug. 2014.
Refbacks
- There are currently no refbacks.